Pfizer warns of hit to financial results on continued coronavirus outbreak

Topics Pfizer | Coronavirus


Pfizer Inc on Thursday warned that the continued spread of the coronavirus globally could have an adverse impact on its business and financial results. The outbreak could have an impact on the company's manufacturing, supply chain and clinical trial operations, Pfizer said under the risk factors section of a regulatory filing.

  "The extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence," the drugmaker added. The.

This article is no longer available in our repository.

There could be multiple reasons for this.